宫颈癌放化疗后局部失败的系统研究:基线侧方解剖间室受累的影响
该研究回顾了225例接受根治性放化疗及图像引导自适应近距离治疗的局部晚期宫颈癌患者,分析局部失败事件按解剖间室的分布及与基线受累的关联。中位随访46.2个月,共发生34例局部失败(24例真性持续,10例新发复发),累及92个间室。基线完整宫旁组织者同侧局部失败率仅1.1%,而基线同侧宫旁受累伴肾积水者同侧局部失败调整比值比为22.2。
要点
- 局部失败最常见于宫颈(79.4%),其次为宫旁(61.8%),宫旁是第二最常累及间室。
- 基线完整宫旁者同侧局部失败率低(1.1%,2/181),且仅沿主韧带扩展。
- 基线同侧宫旁受累伴肾积水与同侧局部失败强相关(aOR 22.2,P<.01),需侧别特异性强化治疗。
核心结论
- 非手术背景下,宫旁是局部失败第二常累及的解剖间室(>60%),仅次于宫颈(80%)。
- 基线完整宫旁的同侧失败频率低(1%)且扩展有限(仅主韧带)。
- 基线肾积水与广泛同侧宫旁复发强相关,需要侧别特异性治疗强化。
研究设计与样本
- 回顾性系统研究,纳入225例连续接受根治性放化疗及图像引导自适应近距离治疗的局部晚期宫颈癌患者。
- 75%为FIGO III-IV期,32%使用腔内/组织间插植近距离治疗,中位随访46.2个月。
- 未接受外照射宫旁推量,分析局部失败的发生率、时机(真性持续 vs 新发复发)、按解剖间室分布及与基线受累的关联(调整比值比)。
主要发现
- 共发生34例局部失败(24例真性持续,10例新发复发),累及92个解剖间室。
- 孤立局部失败为首发复发的比例为55.9%(19/34),3年后无事件,3年/5年总体新发复发率为6.2%,总体局部失败(新发+真性持续)率为16.3%。
- 真性持续者生存更差(2年总生存率19.1% vs 72.9%,P = .04)。
- 最常累及间室为宫颈(79.4%)、宫旁(61.8%)、子宫体(33.3%)、膀胱(14.7%)、阴道(11.8%)、直肠系膜(2.9%)。
- 复发沿主韧带、宫骶韧带、耻骨宫颈韧带方向的比例分别为58.8%、35.3%、23.5%。
关键数值与推荐
- 基线完整宫旁者同侧局部失败率为1.1%(2/181),仅沿主韧带。
- 基线同侧宫旁受累伴肾积水与同侧局部失败相关(aOR 22.2,P < .01),发生率为21.3%(10/47),累及主韧带±耻骨宫颈韧带±宫骶韧带。
- 基线同侧宫旁受累伴肾积水与对侧局部失败无关(aOR 0.4,P = .28)。
临床怎么用
- 对于基线宫旁完整者,同侧局部失败风险低且扩展有限,或可避免不必要的宫旁推量。
- 对于基线同侧宫旁受累伴肾积水者,应考虑侧别特异性的治疗强化。
- 局部失败多沿主韧带、宫骶韧带、耻骨宫颈韧带方向,靶区勾画时应关注这些路径。
局限性
- 回顾性研究设计。
- 单中心数据,样本量225例。
- 未报告外照射宫旁推量,结果可能受近距离治疗技术影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To dissect the local failure (LF) events, including specific rates by anatomic compartments, after definitive chemoradiation therapy for locally advanced cervical cancer. METHODS AND MATERIALS: Records of all consecutive women with locally advanced cervical cancer treated with definitive chemoradiation therapy and image guided adaptive brachytherapy were reviewed, focusing on the local disease status. No patient received external beam radiation therapy parametrial boost. Incidence estimations, timing analysis (true persistence [TP]) versus new recurrence [NR]), calculations of LF rates by anatomic compartments (at the time of LF detection), and test of association of compartment-specific LF with baseline (at diagnosis) involvement (adjusted odds ratio [aOR]), were performed. RESULTS: Among the 225 patients included (75% International Federation of Gynecology and Obstetrics [FIGO] III-IV; 32% intracavitary/interstitial brachytherapy use; median follow-up 46.2 months), 34 LFs occurred (24 TP; 10 NR), involving 92 anatomic compartments. Isolated LF was the first relapse in 55.9% (19/34), with no events after 3 years, resulting in 6.2% 3-year/5-year overall NR and 16.3% 3-year/5-year overall LF (NR + TP) rates. TP had worse survival compared to NR (2 year overall survival: 19.1% vs 72.9%, P = .04). The most involved compartments were the cervix (79.4%), parametrium (PMT) (61.8%), uterine corpus (33.3%), bladder (14.7%), vagina (11.8%), and mesorectum (2.9%). Recurrence followed the cardinal ligament (CL), uterosacral ligament, and pubocervical ligament directions in 58.8%, 35.3%, and 23.5% of cases, respectively. Only 2 intact PMT at diagnosis developed ipsilateral LF (1.1%, 2/181, CL only), whereas baseline ipsilateral PMT involvement with hydronephrosis was associated with ipsilateral LF (aOR 22.2, P < .01, rate: 21.3%, 10/47, involving CL ± pubocervical ligament ± uterosacral ligament), but not with contralateral LF (aOR 0.4, P = .28). CONCLUSIONS: In the nonoperative setting, the lateral PMT is the second most involved anatomic compartment by LF (>60%) after the cervix (80%). An intact baseline PMT has a low frequency (1%) and limited extension (CL only) of ipsilateral failure. In contrast, baseline hydronephrosis is strongly associated with extensive ipsilateral PMT relapse, requiring side-specific treatment intensification.
引用
- Sapienza LG, Guitmann G, Morris CG, et al. A Systematic Study on Local Failure Events Post Chemoradiation Therapy for Cervical Cancer: Understanding the Impact of Baseline Lateral Anatomic Compartment Involvement. Int J Radiat Oncol Biol Phys. 2025. PMID: 40972906. doi:10.1016/j.ijrobp.2025.09.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。